Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New education program helps pregnant women with diabetes take control

NCT ID NCT07060963

Symptom relief Sponsor: Ankara Yildirim Beyazıt University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a nurse-led education program for pregnant women with gestational diabetes. 71 women took part, with some receiving the program and others standard care. The goal was to see if the program improved healthy behaviors, self-confidence, and health beliefs, and reduced complications for mothers and babies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

71 people

The number who actually took part.

Started

Jan 2025

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Able to communicate in Turkish, * Not having conditions that would create communication problems (mental, visual, hearing impairment), * Graduated from at least secondary school, * Having a singleton pregnancy between the 24th and 28th weeks of pregnancy, * Not having been diagnosed with GDM in a previous pregnancy, * Not having been diagnosed with a risky pregnancy (adolescent pregnancy, preeclampsia, eclampsia, hypertension), * Not having a health problem that would prevent exercise (heart disease, respiratory diseases, risk of abortion, orthopedic problems), * Not having to follow a special diet program (Celiac disease, kidney disease, heart disease). * Not having a psychiatric diagnosis (psychosomatic disorders), * Having an endocrine disease known to affect blood glucose levels (hyperthyroidism, hypothyroidism). Exclusion Criteria: * Wanting to leave at any stage of the study, * Not participating in the program at least once after joining the study (Signature chart follow-up, detection of non-continuation of daily follow-up), * Being diagnosed with a risky pregnancy at any stage of the study (preeclampsia, eclampsia, premature membrane rupture, systemic disease) * Incompletely filling in the data collection forms applied during the program.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Apgar score are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

gestational diabetes

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Apgar score Behavior change Maternal and neonatal outcomes Models, theoretical Self-efficacy for decision making

Contacts and locations

Locations

  • Ankara Yıldırım Beyazıt Üniversitesi, Sağlık Bilimleri Fakültesi

    Ankara, Çubuk, 06760, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.